🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jiunn Song

Harvard University

ORCID: 0000-0002-4206-3291

Also affiliated with Massachusetts General Hospital

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.4Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Lipid Droplet Knowledge Portal: A resource for systematic analyses of lipid droplet biology

Developmental Cell(2022)10.1016/j.devcel.2022.01.003
Top 9%
2.4DataRank
Top 9%80 citations

Katlyn R. Gabriel, Scott Frendo‐Cumbo, Natalie Krahmer, Jiunn Song, Leena Kuruvilla +12 more

Papers

Driven by 8 papers — median percentile 91. Top paper: “The Lipid Droplet Knowledge Portal: A resource for systematic analyses of lipid droplet biology”.

The Lipid Droplet Knowledge Portal: A resource for systematic analyses of lipid droplet biology

Developmental Cell(2022)10.1016/j.devcel.2022.01.003
Top 9%
2.4DataRank
Top 9%80 citations

Katlyn R. Gabriel, Scott Frendo‐Cumbo, Natalie Krahmer, Jiunn Song, Leena Kuruvilla +12 more

A good step toward low-cost prognostication of liver-related outcome awaits more validation

Journal of Hepatology(2022)10.1016/j.jhep.2022.04.008
N/A
0DataRank · unranked
12 citations

Z. Gordon Jiang, Jiunn Song

Mechanism of action for small-molecule inhibitors of triacylglycerol synthesis

Nature Communications(2023)10.1038/s41467-023-38934-3
N/A
0DataRank · unranked
15 citations

Kun Wang, Kangkang Song, Xu Chen, Jiunn Song, Chia‐Wei Lee +4 more

GLP ‐ 1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching

Liver International(2025)10.1111/liv.70447
N/A
0DataRank · unranked
4 citations

Tushar Kamath, Vy H. Nguyen, Eric M. Przybyszewski, Jiunn Song, Allison J. Carroll +5 more

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Reduced Hepatocellular Carcinoma Risk in Patients With Type 2 Diabetes

The American Journal of Gastroenterology(2025)10.14309/ajg.0000000000003889
N/A
0DataRank · unranked
1 citations

Vy H. Nguyen, Eric M. Przybyszewski, Jiunn Song, Allison J. Carroll, Megan Michta +4 more

Comparative effectiveness of antidiabetic therapies on hepatic decompensation in patients with type 2 diabetes: A target trial emulation

JHEP Reports(2025)10.1016/j.jhepr.2025.101624
N/A
0DataRank · unranked
0 citations

Ana Verma, Vy H. Nguyen, Eric M. Przybyszewski, Jiunn Song, Allison J. Carroll +5 more

Identification of two pathways mediating protein targeting from ER to lipid droplets

Nature Cell Biology(2022)10.1038/s41556-022-00974-0
N/A
0DataRank · unranked
106 citations

Arda Mizrak, Chia‐Wei Lee, Marcelo Cicconet, Zon Weng Lai, Wei‐Chun Tang +5 more

Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis

Clinical and Molecular Hepatology(2025)10.3350/cmh.2025.0825
N/A
0DataRank · unranked
0 citations

Daniel Fulop, Vy H. Nguyen, Eric M. Przybyszewski, Jiunn Song, Allison J. Carroll +5 more